N398 Final Flashcards
metformin
- used to prevent DM 2
- inhibits glucose production in the liver and reduces absorption in the gut
- can lead to lactic acid build up
- does NOT stimulate insulin release
- contraindication within 48 hrs of IV contrast
glipizide
- sulfonylureas
- used to prevent DM 2
- stimulates release of insulin from pancreatic islets (if pancreas doesnt work–this drug wont)
- AE: hypoglycemia
repaglinitde
- used to prevent DM 2
- stimulates release of insulin from pancreatic islets (if pancreas doesnt work–this drug wont)
- AE: hypoglycemia (absorbed rapidly in the gut)
sitagliptin
-used to prevent DM 2
-blocks DDP-4 and stimulates glucose dependent release of insulin and suppresses postprandial release of glucagon
AE: hypoglycemia, pancreatitis, Stevens-johnson syndrome
liraglutide
- used prevent DM 2
- slows gastric emptying, stimulates glucose dependent insulin release
- SQ injection
pioglitazone
- used to prevent to DM 2
- reduces insulin resistance and decrease glucose production
- AE: fluid retention, hypoglycemia
insulin: Lispro
- used to prevent DM 1
- rapid acting (meal time fixes)
- AE: hypoglycemia, hyperkalemia, allergic reactions
insulin: regular
- prevent DM 1
- short duration
insulin: NPH
- prevent DM 1
- intermediate duration
insulin: glargine
- prevent DM 1
- long duration (helps mimics the pancreas)
- cant mix
phenytoin
-anti-epileptic drug
-used for seizures except absence
-selective inhibition of Na+ channels
AE: gengivial hyperplasia, swelling, SJS, teratogenic in pregnancy (cleft palate, hydrocephalus, renal), purple glove syndrome
-narrow therapeutic index
fosphenytoin
- pro-drug of phenytoin
- less side effects (no purple glove syndrome)
carbamazepine
- anti-epileptic drug
- used for partial seizures and tonic-clonic seizures
- suppresses high frequency neuronal dischange in and around seizure foci
- AE: CNS, hematologic, increased risk of spina bifida, hyponatremia, and rashes
- autoinduction (metabolized in the liver)
divalproex
- antiepileptic drug
- sodium channel blockage, inhibitory of GABA, suppression of calcium influx
- AE: hepatotoxicity, pancreatitis, hyperammonia, tetrogenic in 1st trimester (neural tube and congnitive)
- comes in extended release, delayed release, sprinkles
levetiracetam
- antiepileptic drug
- mechanism is unknown
- AE: drownsiness and asthenia
- minimal drug interactions